- About Us
- News & Events
- Get Information
- Our Research
- Treatment Trials
Associate Professor Kate Hoy receives grant for Alzheimer’s disease research
Congratulations to Associate Professor Kate Hoy, who has received a Mason Foundation National Medical Program Grant for the project ‘A randomized controlled trial of Theta Burst Stimulation for the treatment of mild to moderate Alzheimer’s disease,’ a novel treatment approach.
Alzheimer’s disease is characterised by progressive decline in cognitive functioning in most areas. Although there are medications that can slow the progression of symptoms somewhat, there are currently no effective treatments for these hallmark symptoms.
The trial is due to start in April 2016. Patients with mild to moderate Alzheimer’s will be randomised to a six week treatment course of either active or sham Theta Burst Stimulation. In each treatment session stimulation will be sequentially provided to four brain regions: the left and right dorsolateral prefrontal cortex and the left and right parietal cortex. They are predicting active treatment will result in improved cognition, improved functional outcomes, and less cognitive decline.